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New Universal Definition  
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Athanasios G. Pipilis, MD
Recently, a joint ESC/ACCF/AHA/WHF Task Force published an expert consen-
sus document on the universal definition of myocardial infarction [1]. The following 
points are extracts from this document that summarize its main features.
The main reason for agreeing on a new definition of myocardial infarction derives 
from the development and the wide availability of very sensitive and specific serological 
biomarkers that are able to detect even minimal myocardial necrosis.
Acute myocardial infarction is diagnosed when there is evidence of myocardial 
cell necrosis in the clinical setting of myocardial ischemia. In contrast to the historical 
World Health Organization (WHO) definition where symptoms, ECG and enzymes 
had equal weight for the diagnosis (the presence of any two would suffice), today bi-
omarkers take precedence with imaging having also a diagnostic role. Consequently, 
acute myocardial infarction is diagnosed if a rise and fall of cardiac biomarkers (prefer-
ably troponin) is detected together with at least one of the following: a) symptoms of 
ischemia, b) new ST-T changes or new left bundle branch block (LBBB), c) development 
of pathological Q waves and d) imaging evidence of new loss of viable myocardium or 
new regional wall motion abnormality.
Prior myocardial infarction requires for its diagnosis any of the following criteria: 
a) new Q waves, b) imaging of a regional loss of viable myocardium that is thinned and 
fails to contract and c) pathological findings of a healed or healing myocardium.
c L I N I c A L  c L A s s I f I c A t I O N  O f  m Y O c A r D I A L  
I N f A r c t I O N
The clinical classification of myocardial infarction consists of 5 types:
 a) Type 1: Spontaneous myocardial infarction related to ischemia due to a primary coronary 
event (plaque erosion, rupture, fissuring, dissection)
 b) Type 2: Myocardial infarction secondary to ischemia due to either increased oxygen de-
mand or decreased supply (spasm, embolism, anemia, arrhythmia, hypertension, hypoten-
sion)
 c) Type 3: Sudden unexpected death (biomarkers may have not been obtained or not yet 
raised)
 d) Type 4: Myocardial infarction associated with percutaneous coronary intervention (PCI) 
(type 4a) and stent thrombosis (type 4b). To diagnose peri-procedural necrosis in patients 
with normal baseline troponin values, biomarkers should be greater than 3 times the th 
percentile URL (upper reference limit).
 e) Type 5: Myocardial infarction associated with coronary artery bypass grafting (CABG). To 
diagnose peri-operative necrosis biomarkers should be greater than 5 times the th per-
centile URL, together with new Q waves, LBBB, graft or native artery occlusion or imaging 
of new loss of viable myocardium.
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c A r D I A c  b I O m A r K E r s ,  E c G  &  I m A G -
I N G
Although elevation of troponin is indicative of myocardial 
cell damage it does not indicate the mechanism. Therefore 
several conditions with elevated troponin do not imply overt 
ischemic heart disease (for example cardiac failure, renal 
failure, drug toxicity, sepsis, pulmonary embolism).
Electrocardiographic manifestation of ischemia that may 
lead to myocardial infarction are ST segment elevation (with 
hyperacute symmetrical increased amplitude T-waves being 
an early finding) or ST segment depression. New ST eleva-
tion requires a J point in two contiguous leads ≥0.2 mV in 
men and ≥0.15 mV in women for leads V2-V3 and ≥0.1 mV 
for the other leads. New ST depression and T wave changes 
requires horizontal or down-sloping depression ≥0.05 mV in 
two contiguous leads and/or T wave inversion ≥0.1 mV in two 
contiguous leads with a prominent R wave or R/S ratio >1.
Imaging techniques are applied in the acute and the 
healing or healed phase of myocardial infarction. Rest 
echocardiography is the commonest method used but cannot 
distinguish ischemia from infarction. Radionuclide imaging, 
stress echocardiography and magnetic resonance imaging 
(MRI) can be used to identify viability of myocardial tissue.
I m P L I c A t I O N s
The new definition of myocardial infarction has several 
epidemiological and clinical trial implications. In epidemiol-
ogy, since biomarkers are able to detect smaller infarcts the 
incidence of non STEMI is increased while unstable angina is 
becoming a rarer diagnosis. Therefore, comparison of tempo-
ral trends of myocardial infarction incidence in registries will 
be affected and historical controls may be difficult to evaluate. 
In clinical trials with myocardial infarction as an outcome, an 
attempt to quantify myocardial damage by multiples of the 
th percentile URL of the biomarker is encouraged so that 
comparisons between various severity categories of infarction 
can be made possible.
Finally, the new definition, with more patients with limited 
myocardial injuries being diagnosed as myocardial infarctions 
may have psychological, legal, insurance and professional 
consequences. 
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